Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
1.015
-0.075 (-6.88%)
Feb 12, 2026, 12:36 PM EST - Market open

Rockwell Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
75.58101.4983.6172.8161.9362.2
Revenue Growth (YoY)
-23.60%21.38%14.84%17.57%-0.43%1.46%
Cost of Revenue
64.1384.0174.9168.7364.3559.47
Gross Profit
11.4517.488.74.08-2.422.73
Selling, General & Admin
16.2616.8614.2717.7421.0824.05
Research & Development
00.021.113.126.847.09
Operating Expenses
16.2616.8815.3720.8627.9231.15
Operating Income
-4.810.61-6.67-16.78-30.34-28.42
Interest Expense
-1.13-1.25-2.3-1.94-2.36-1.88
Interest & Investment Income
0.220.090.210.030.020.24
EBT Excluding Unusual Items
-5.72-0.55-8.76-18.68-32.67-30.06
Gain (Loss) on Sale of Investments
0.20.070.320-0.01
Other Unusual Items
------0.84
Pretax Income
-5.52-0.48-8.44-18.68-32.67-30.89
Net Income
-5.52-0.48-8.44-18.68-32.67-30.89
Preferred Dividends & Other Adjustments
0.420.30.15---
Net Income to Common
-5.93-0.78-8.59-18.68-32.67-30.89
Shares Outstanding (Basic)
3431231497
Shares Outstanding (Diluted)
3431231497
Shares Change (YoY)
14.40%33.17%63.05%67.77%24.02%24.14%
EPS (Basic)
-0.17-0.03-0.37-1.31-3.83-4.49
EPS (Diluted)
-0.17-0.03-0.37-1.31-3.83-4.49
Free Cash Flow
-2.943.19-9.7-17.21-34.06-30.69
Free Cash Flow Per Share
-0.090.10-0.42-1.20-3.99-4.46
Gross Margin
15.15%17.23%10.41%5.60%-3.91%4.38%
Operating Margin
-6.37%0.60%-7.98%-23.05%-48.98%-45.69%
Profit Margin
-7.85%-0.77%-10.27%-25.65%-52.76%-49.66%
Free Cash Flow Margin
-3.89%3.14%-11.60%-23.64%-54.99%-49.34%
EBITDA
-2.622.79-5.23-16.2-29.67-27.59
EBITDA Margin
-3.47%2.75%-6.25%-22.25%-47.91%-44.35%
D&A For EBITDA
2.192.181.440.580.670.83
EBIT
-4.810.61-6.67-16.78-30.34-28.42
EBIT Margin
-6.37%0.60%-7.98%-23.05%-48.98%-45.69%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q